News NICE agrees to look again at Alzheimer's drug Leqembi Eisai and Biogen have another chance to convince NICE that the NHS should cover the cost of Alzheimer's therapy Leqembi.
News FDA starts review of Roche's Gazyva in lupus nephritis FDA starts a review of Roche's Gazyva as a treatment for lupus nephritis, an indication that analysts think could unlock renewed sales growth.
News Lawrence Tallon will lead MHRA after June Raine retires Lawrence Tallon has been named head of the MHRA, effective 1st April, replacing Dame June Raine who is retiring.
News FDA approves first generics of anticoagulant Xarelto The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto.
News Roche ends the 30-year US hiatus in new stroke drugs Genentech has won FDA approval for its clot-buster TNKase as a treatment for acute ischaemic stroke, after almost abandoning the project in 2023.
News Pharma urges NHS to put medicines at heart of 10-year plan The UK pharma industry has warned that declining access to new medicines in England will undermine the government's efforts to rebuild the NHS.
Digital On the future of AI in life sciences, with women at the helm Dive into a conversation on women in AI, with: Kate Eversole, Pharma Brands; Celine Parmentier, Real Chemistry; and Emma Slade, Tangram Therapeutics.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
